As an ISG, IFIT1 has been implicated in the progression of HPV-related diseases, including HPV-associated head and neck squamous cell carcinoma (HNSCC), cervical cancer, and other HPV-related malignancies [40, 56–58]. Here, IFIT1 is linked to cervical cancer.